Machine learning-driven insights into retention mechanism in IAM chromatography of anticancer sulfonamides: Implications for biological efficacy.

Journal: Journal of chromatography. A
PMID:

Abstract

Machine learning (ML) tools offer new opportunities in drug discovery, especially for enhancing our understanding of molecular interactions with biological systems. This study develops a comprehensive quantitative structure-retention relationship (QSRR) model to elucidate sulfonamides' binding mechanisms to phospholipids via immobilized artificial membrane (IAM) chromatography. Using a dataset of over 500 sulfonamide derivatives, we combined experimental IAM-HPLC data with computational molecular descriptors and ML techniques, achieving robust predictive models. The descriptor-based LASSO regression model effectively predicts retention behavior (R² = 0.71, Q² = 0.77), providing insights into molecular interactions. Critical descriptors influencing these interactions include aqueous solubility, nitrogen-to-oxygen ratio, atomic and mass descriptors such as atom and ring count, as well as logP, indicative of molecular lipophilicity. Furthermore, the fingerprint-based predictive support vector machine model demonstrated superior performance (R² = 0.899 Q² = 0.810) highlighting structural features such as benzene rings and nitrogen-attached fragments as crucial factors in determining phospholipid affinity. Furthermore, predictive models for anticancer activities across three cell lines-HCT-116, HeLa, and MCF-7-were constructed, highlighting CHI value as a critical determinant of bioactivity. The findings underscore the utility of integrated ML and chromatographic approaches in streamlining the drug development pipeline, improving predictions of biological efficacy while reducing experimental burden.

Authors

  • Wiktor Nisterenko
    Department of Physical Chemistry, Medical University of Gdansk, Al. Gen. Hallera 107, 80-416 Gdansk, Poland.
  • Beata Żołnowska
    Department of Organic Chemistry, Medical University of Gdansk, Al. Gen. Hallera 107, 80-416 Gdansk, Poland.
  • Jiayin Deng
    State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau, China. Electronic address: mc05824@umac.mo.
  • Dominika Zgoda
    Department of Physical Chemistry, Medical University of Gdansk, Al. Gen. Hallera 107, 80-416 Gdansk, Poland.
  • Alicja Różycka
    Department of Physical Chemistry, Medical University of Gdansk, Al. Gen. Hallera 107, 80-416 Gdansk, Poland.
  • Katarzyna Ewa Greber
    Department of Physical Chemistry, Medical University of Gdansk, Al. Gen. Hallera 107, 80-416 Gdansk, Poland.
  • Aneta Pogorzelska
    Department of Organic Chemistry, Medical University of Gdansk, Al. Gen. Hallera 107, 80-416 Gdansk, Poland.
  • Krzysztof Szafrański
    Department of Organic Chemistry, Medical University of Gdansk, Al. Gen. Hallera 107, 80-416 Gdansk, Poland.
  • Anita Bułakowska
    Department of Organic Chemistry, Medical University of Gdansk, Al. Gen. Hallera 107, 80-416 Gdansk, Poland.
  • Łukasz Tomorowicz
    Department of Pharmacy, University of Illinois Chicago, 833 S Wood St, Chicago, IL 60612 USA.
  • Anna Kawiak
    Department of Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, ul. Abrahama 58, 80-307 Gdansk, Poland.
  • Wiesław Sawicki
    Department of Physical Chemistry, Medical University of Gdańsk, Aleja Gen. Hallera 107, Gdańsk 80-416, Poland.
  • Defang Ouyang
    State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China.
  • Jarosław Sławiński
    Department of Organic Chemistry, Medical University of Gdansk, Al. Gen. Hallera 107, 80-416 Gdansk, Poland.
  • Krzesimir Ciura
    Department of Physical Chemistry, Medical University of Gdańsk, Aleja Gen. Hallera 107, Gdańsk 80-416, Poland; QSAR Lab Ltd., Trzy Lipy 3St. Gdańsk 80-172, Poland. Electronic address: krzesimir.ciura@gumed.edu.pl.